ArticleInfectious diseases of poverty2026
Climate change reshapes the potential transmission risk of human alveolar and cystic echinococcosis in western China: a projection based on MaxEnt models.
Article in Infectious diseases of poverty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundEchinococcosis, a severe zoonotic parasitic disease, imposes a significant health burden in western China, primarily as alveolar (AE) and cystic (CE) forms caused by Echinococcus multilocularis (Em) and E. granulosus sensu lato (Egsl), respectively. Its transmission, tied to a complex host cycle, is strongly influenced by climatic factors. This study aimed to model the ecological niches of these parasites, validate predictions with epidemiological data, and project the impact of climate change on future transmission risk geography.
methodsUtilizing location data of 1247 human cases diagnosed in western China from 1981 to 2016, obtained from the National Echinococcosis Control Program, and contemporary climate data, we developed optimized Maximum Entropy (MaxEnt) models. This involved defining an appropriate spatial resolution, screening 19 bioclimatic variables to select key predictors (7 for Em, 6 for Egsl), and identifying optimal model parameters. Model performance was evaluated using the Area Under the Curve (AUC) and AUC of 10% Receiver Operating Characteristic (AUCpROC) curve, and validity was assessed via correlation with county-level incidence. Future habitat suitability was projected for multiple periods (2011-2100) under three climate scenarios (SSP-126, SSP-370, SSP-585) generated by 5 global climate models.
resultsThe models demonstrated high predictive accuracy (AUC > 0.92; AUCpROC: 0.084 for Em, 0.070 for Egsl) and a significant positive correlation with incidence (ρ > 0.6, P < 0.0001). Em and Egsl exhibited distinct climatic niches: Em prefers cool, stable climates with moderate summer moisture, while Egsl spreads in areas with dry-cold winters, warm-humid summers, and moderate seasonality. Future projections reveal a spatially heterogeneous reshaping of risk. While overall suitability increases, Em's suitable area is projected to shift toward higher altitudes (e.g., expanding in Qinghai and Xizang but contracting in Ningxia and Gansu). In contrast, Egsl shows widespread outward expansion from current endemic margins, particularly across the Tibetan Plateau. Qinghai and Xizang are identified as key expansion hotspots for both Em and Egsl.
conclusionThe findings confirm distinct ecological drivers for the suitability of Em and Egsl, and indicate that climate change will potentially shift the endemic areas of AE and expand those of CE in western China. This underscores the necessity for forward-looking, spatially targeted surveillance and control strategies, informed by a One Health approach, to mitigate the evolving burden of echinococcosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.